Technology

Latest News

May 16th 2016

Payers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that.

May 15th 2016

Califf Seeks Evidence to Guide Regulatory Decisions

By Jill Wechsler, Pharm Exec’s Washington Correspondent

May 13th 2016

Takeda Receives Grant from Bill & Melinda Gates Foundation

May 6th 2016

Opdivo Will Help Boost Non-Small Cell Lung Cancer Market in Asia-Pac

May 5th 2016

Experts Urge Caution in Expansion of Drug Development Incentive Program

UK Cell and Gene Therapy Manufacturing Capability on the Rise

May 5th 2016

May 05, 2016.

Sanofi's Letter to the Medivation Board

May 5th 2016

May 05, 2016.

Global Dermatology Market Set to Reach $33.7 Billion by 2022 Despite Patent Expiries

May 4th 2016

May 04, 2016.

Valeant Board Shake-Up

May 3rd 2016

May 03, 2016.

EMD Serono Expansion to Create 150 New Jobs in Massachusetts

May 3rd 2016

May 03, 2016.

IMS and Quintiles Announce Merger

ByPharmExec Staff

May 3rd 2016

Combined company will have market value of around $18 billion, reports Reuters.

GSK Gel Endorsed by EMA to Prevent Umbilical Cord Infections Outside EU

April 29th 2016

April 29, 2016.

Pharma Failing to Improve Gender Diversity in Workforce

April 29th 2016

April 29, 2016.

Hematological Cancers Market Expected to "More Than Double" by 2022

April 28th 2016

April 28, 2016.

Data Unleashed: Cooperation Among Competitors

ByPatrick Homer,Matt Gross

April 27th 2016

Pharmaceutical Executive

Charting two years of collaborative progress in clinical trial data sharing.

Italy's Industry Value to Drop to $18.6 Billion by 2020

April 27th 2016

April 27, 2016.

WHO Releases Report on Eliminating Malaria

ByPharmaceutical Technology

April 26th 2016

Pharmaceutical Executive

April 26, 2016.

Disease Interception and the US National Cancer Moonshot

ByDIA

April 26th 2016

April 26, 2016.

World Excipients Market to Reach $6.4 Billion by 2020, Says Report

April 26th 2016

April 26, 2016.

Pharm Exec's Emerging Pharma Leaders 2016 — Last Chance to Nominate

ByPharmExec Staff

April 25th 2016

March 23, 2016.

Perrigo Confirms Papa Exit

April 25th 2016

April 25, 2016.

Europe: Orphans Under Attack Again

ByPeter O'Donnell

April 21st 2016

Pharmaceutical Executive

April, 21, 2016.

FDA's Breakthrough Designation is Working, Says Report

ByJill Wechsler, Pharm Exec’s Washington Correspondent

April 21st 2016

Pharmaceutical Executive

April 21, 2016.

European Physicians Want More Detail on Biosimilar Labels

April 19th 2016

April 19, 2016.

Shire Announces $400 Million Ireland Investment

ByBioPharm International

April 18th 2016

Pharmaceutical Executive

April 18, 2016.

Global Viral Infections Market to Reach $117.6 Billion by 2021

April 14th 2016

April 14, 2016.

Schizophrenia Treatment Pipeline "Weak" But Has Potential

April 13th 2016

April 13, 2016.

Pressure Builds to Revamp Off-Label Marketing Rules

ByJill Wechsler, Pharm Exec’s Washington Correspondent

April 12th 2016

Pharmaceutical Executive

April 12, 2016.

FDA Approves Remicade Biosimilar

ByJill Wechsler, Pharm Exec’s Washington Correspondent

April 6th 2016

More than a year after approving its first biosimilar, FDA has authorized a second therapy in this category.

FDA Releases Draft Guidance on Labeling of Biosimilars

April 4th 2016

Pharmaceutical Executive

April 04, 2016.

Technology

Latest News

UK Cell and Gene Therapy Manufacturing Capability on the Rise

Sanofi's Letter to the Medivation Board

Global Dermatology Market Set to Reach $33.7 Billion by 2022 Despite Patent Expiries

Valeant Board Shake-Up

EMD Serono Expansion to Create 150 New Jobs in Massachusetts

IMS and Quintiles Announce Merger

GSK Gel Endorsed by EMA to Prevent Umbilical Cord Infections Outside EU

Pharma Failing to Improve Gender Diversity in Workforce

Hematological Cancers Market Expected to "More Than Double" by 2022

Data Unleashed: Cooperation Among Competitors

Italy's Industry Value to Drop to $18.6 Billion by 2020

WHO Releases Report on Eliminating Malaria

Disease Interception and the US National Cancer Moonshot

World Excipients Market to Reach $6.4 Billion by 2020, Says Report

Pharm Exec's Emerging Pharma Leaders 2016 — Last Chance to Nominate

Perrigo Confirms Papa Exit

Europe: Orphans Under Attack Again

FDA's Breakthrough Designation is Working, Says Report

European Physicians Want More Detail on Biosimilar Labels

Shire Announces $400 Million Ireland Investment

Global Viral Infections Market to Reach $117.6 Billion by 2021

Schizophrenia Treatment Pipeline "Weak" But Has Potential

Pressure Builds to Revamp Off-Label Marketing Rules

FDA Approves Remicade Biosimilar

FDA Releases Draft Guidance on Labeling of Biosimilars

Trending on PharmExec

Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal

Marty Makary Out as FDA Commissioner: Report

The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff

From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box

Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables